# NIH Reporter #5P30GM159561-02

COBRE Phase III

**Recipient:** University of Arkansas for Medical Sciences (UAMS)

**Award Amount:** $1,147,500.00
**Ceiling:** $1,147,500.00

**Awarded:** June 18, 2026

**Identifier:** 5P30GM159561-02

The National Institute of General Medical Sciences awarded the University of Arkansas for Medical Sciences $1,147,500 for COBRE Phase III, supporting research and infrastructure focused on understanding and reducing adverse effects of cancer therapy.

### Description

Funding for the Center for Studies of Host Response to Cancer Therapy at the University of Arkansas for Medical Sciences. The center supports multidisciplinary research into cancer therapy side effects, including their mechanisms, early detection, and prevention or treatment.

[View original record](https://reporter.nih.gov/search/J7l2tQ4hHkqRePwGq3m5kA/project-details/11378541)